JP Morgan Chase
OKYO icon

JP Morgan Chase’s OKYO Pharma OKYO Stock Holding History

JP Morgan Chase’s Portfolio OKYO Stock Details OKYO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.01K Buy
+1,480
New +$2.23K ﹤0.01% 7463

Other funds holding OKYO

Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $159M AUM 62.27% 1-Year Est. Return
Choreo LLC
Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return
Quantinno Capital Management
Quantinno Capital Management New York $106B AUM 29.93% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $87.3B AUM 22.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
HRT Financial
HRT Financial New York $57.2B AUM 52.85% 1-Year Est. Return
Steward Partners Investment Advisory
Steward Partners Investment Advisory New York $21.5B AUM 22.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Continuum Advisory
Continuum Advisory Eagle, Idaho $1.23B AUM 21.4% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

JP Morgan Chase's OKYO Position: Q3 2026 in Review

JP Morgan Chase opened a new position in OKYO Pharma (OKYO) in Q3 2026: 1,480 shares worth $2.01K. The stake represents ﹤0.01% of the portfolio and ranks #7463 among its holdings.

11 funds tracked by Wall St. Rank hold OKYO as of Q3 2026.

  • JP Morgan Chase held 1,480 shares of OKYO Pharma worth $2.01K as of Q3 2026.
  • OKYO Pharma was a new JP Morgan Chase position in Q3 2026.
  • OKYO Pharma made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #7463 holding.
  • 11 funds tracked by Wall St. Rank held OKYO Pharma as of Q3 2026.

Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.